| Pharmaceutical active ingredients: |
| Terbinafine Hydrochloride |
| Available forms, composition and doses of Lamican: |
| Tablets; Oral; Terbinafine Hydrochloride 125 mgTablets; Oral; Terbinafine Hydrochloride 250 mg |
| Lamican medical category: |
| Human:AllylaminesAntifungalsTopical antifungals and antiparasites |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| D01AE15 - TerbinafineD01BA02 - Terbinafine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Canonpharma Production |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Gen-Terbinafine | Terbinafine Hydrochloride | Genpharm |
| Helvepedin | Terbinafine Hydrochloride | Helvepharm |
| Interbi | Terbinafine Hydrochloride | Interbat; HealthCare PharmaScience; Via Hong |
| Jamp-Terbinafine | Terbinafine Hydrochloride | Jamp Pharma |
| Lamasil | Terbinafine Hydrochloride | Novartis |
| Lamifen | Terbinafine Hydrochloride | Wander; Zuellig Pharma |
| Lamisil | Terbinafine Hydrochloride | Novartis; DKSH; Four Star; Zuellig Pharma |
| Lamisil 1 | Terbinafine Hydrochloride | Novartis |
| Lamisil AT | Terbinafine Hydrochloride | Novartis |
| Lamisil Derm | Terbinafine Hydrochloride | Novartis; Zuellig Pharma |